Haemato AG

Company Description

HAEMATO has been committed for over 15 years as a pharmaceutical manufacturer and wholesaler to actively contributing to cost reduction in the healthcare sector, so that every patient can benefit from the latest therapies and treatment concepts, even if these are often very expensive. In addition, the Group focuses on the development and distribution of own brands in the Lifestyle & Aesthetics segment.

HAEMATO covers chronic diseases and high-priced therapies in particular with its own product portfolio. The focus is on the five therapeutic areas of HIV/AIDS, neurology, oncology, rheumatology and ophthalmology. These therapeutic areas include innovative, patent-protected drugs as well as biosimilars and generics. The product portfolio is rounded off with narcotics, which also include cannabis products.

Served Area

Worldwide